Trial intelligence / Profile preview

Phenobarbital vs topiramate vs levetiracetam for neonatal seizures

IRCT20200115046137N1Phase 2Completed

Sponsor
Tabriz University of Medical Sciences
Start
Aug 2020
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in neonatal seizure comparing Phenobarbital, Topiramate and Levetiracetam (3 arms). Primary endpoints: Effect of drugs on treatment of various seizure types, Reduction in number of seizures and 1 more. Started Aug 2020; status: completed.

02

Drugs

phenobarbitaltopiramatelevetiracetam
03

Conditions

neonatal seizure

Beyond the preview

Go deeper on IRCT20200115046137N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200115046137N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call